BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Streba LAM, Vere CC, Rogoveanu I, Streba CT. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question. World J Gastroenterol 2015; 21(14): 4103-4110 [PMID: 25892859 DOI: 10.3748/wjg.v21.i14.4103]
URL: https://www.wjgnet.com/1948-5182/full/v21/i14/4103.htm
Number Citing Articles
1
Pasquale Agosti, Carlo Sabbà, Antonio Mazzocca. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironmentBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(2): 607 doi: 10.1016/j.bbadis.2017.11.026
2
Judith Lauvai, Monika Schumacher, Fernanda Dias Bartolomeu Abadio Finco, Lutz Graeve. Bacaba phenolic extract attenuates adipogenesis by down-regulating PPARγ and C/EBPα in 3T3-L1 cellsNFS Journal 2017; 9: 8 doi: 10.1016/j.nfs.2017.09.001
3
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic reviewObesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
4
P. Shabani, S. Emamgholipour, M. Doosti. Advances in Clinical Chemistry 2017; 79: 1 doi: 10.1016/bs.acc.2016.10.002
5
D. T. Reid, B. Eksteen. Murine models provide insight to the development of non-alcoholic fatty liver diseaseNutrition Research Reviews 2015; 28(2): 133 doi: 10.1017/S0954422415000128
6
Yasin Şenol, Ozan Kaplan, Cem Varan, Nurbanu Demirtürk, Selin Öncül, Bilge Başak Fidan, Ayşe Ercan, Erem Bilensoy, Mustafa Çelebier. Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell linesJournal of Drug Delivery Science and Technology 2023; 79: 104017 doi: 10.1016/j.jddst.2022.104017
7
John C. McVey, Qianfei Zhang, Tim F. Greten, Chi Ma. Inflammation, Infection, and Microbiome in CancersPhysiology in Health and Disease 2021; : 199 doi: 10.1007/978-3-030-67951-4_7
8
I. G. Nikitin, A. S. Tikhomirova, T. A. Zhinzhilo, E. V. Vinnitskaya, Y. G. Sandler, V. A. Kislyakov, I. G. Fedorov. Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 PolymorphismThe Russian Archives of Internal Medicine 2020; 10(2): 148 doi: 10.20514/2226-6704-2020-10-2-148-154
9
Fatemeh Rahimi, Yahya Pasdar, Mojtaba Kaviani, Soheil Abbasi, Hillary Fry, Azita Hekmatdoost, Omid Nikpayam, Golbon Sohrab, Mansoaur Rezaei, Seyed Mostafa Nachvak, Reza Mohammadi, Gayatri K. Athalye-Jape. Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple-Blind, Placebo-Controlled TrialInternational Journal of Clinical Practice 2022; 2022: 1 doi: 10.1155/2022/2967977
10
Hiroki Nishikawa, Hirayuki Enomoto, Shuhei Nishiguchi, Hiroko Iijima. Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical ImpactInternational Journal of Molecular Sciences 2021; 22(4): 1917 doi: 10.3390/ijms22041917
11
Chi Ma, Qianfei Zhang, Tim F. Greten. MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic targetCellular Immunology 2021; 361: 104295 doi: 10.1016/j.cellimm.2021.104295
12
Xushan Yang, Linye Sun, Dongliang Feng, Yudi Deng, Wenzhen Liao. A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternationThe Journal of Nutritional Biochemistry 2023; 118: 109353 doi: 10.1016/j.jnutbio.2023.109353
13
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, Tracy Robson, Stephanie Annett. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targetsFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1148934
14
Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul. Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver diseaseClinical and Molecular Hepatology 2020; 26(4): 705 doi: 10.3350/cmh.2020.0166
15
Xin Zhang, Yuyin Xu, Qianming Bai, Xiaobo Li, Jing Han, Yingyong Hou, Yuan Ji, Zhigang Zhang. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(1): G87 doi: 10.1152/ajpgi.00380.2019
16
Gang Wang, Ning Zhuo, Zhichun Liu. Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor for Young-Onset Digestive Tract CancersJournal of Clinical Oncology 2023; 41(32): 5070 doi: 10.1200/JCO.23.01039
17
Natalia Pydyn, Katarzyna Miękus, Jolanta Jura, Jerzy Kotlinowski. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitisPharmacological Reports 2020; 72(1): 1 doi: 10.1007/s43440-019-00020-1
18
Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related CancersInternational Journal of Molecular Sciences 2022; 23(19): 11188 doi: 10.3390/ijms231911188
19
Natalia Pydyn, Dariusz Żurawek, Joanna Kozieł, Edyta Kus, Kamila Wojnar‐Lason, Agnieszka Jasztal, Mingui Fu, Jolanta Jura, Jerzy Kotlinowski. Role of Mcpip1 in obesity‐induced hepatic steatosis as determined by myeloid and liver‐specific conditional knockoutsThe FEBS Journal 2021; 288(22): 6563 doi: 10.1111/febs.16040
20
Natalia Belemets, Nazarii Kobyliak, Oleksandr Virchenko, Tetyana Falalyeyeva, Tsyryuk Olena, Petro Bodnar, Oleksiy Savchuk, Tetyana Galenova, Martin Caprnda, Luis Rodrigo, Lubomir Skladany, Delian Delev, Radka Opatrilova, Peter Kruzliak, Tetyana Beregova, Lyudmyla Ostapchenko. Effects of polyphenol compounds melanin on NAFLD/NASH preventionBiomedicine & Pharmacotherapy 2017; 88: 267 doi: 10.1016/j.biopha.2017.01.028
21
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
22
Chun-Xiao Liu, Rui-Xing Yin, Zong-Hu Shi, Guo-Xiong Deng, Peng-Fei Zheng, Bi-Liu Wei, Yao-Zong Guan. EHBP1 SNPs, Their Haplotypes, and Gene–Environment Interactive Effects on Serum Lipid LevelsACS Omega 2020; 5(13): 7158 doi: 10.1021/acsomega.9b03522
23
Pan Deng, Jazmyne Barney, Michael C. Petriello, Andrew J. Morris, Banrida Wahlang, Bernhard Hennig. Hepatic metabolomics reveals that liver injury increases PCB 126-induced oxidative stress and metabolic dysfunctionChemosphere 2019; 217: 140 doi: 10.1016/j.chemosphere.2018.10.196
24
Emir Muzurović, Dimitri P. Mikhailidis, Christos Mantzoros. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular riskMetabolism 2021; 119: 154770 doi: 10.1016/j.metabol.2021.154770
25
Ghazaleh Pourali, Zeinab S. Hosseini, Mina Maftooh, Elham Nazari, Majid Khazaei, Mohammadreza Nassiri, Seyed M. Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad A. Kiani, Amir Avan. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver DiseaseCurrent Drug Targets 2023; 24(4): 300 doi: 10.2174/1389450124666230113150116
26
H. Nina Kim, Craig W. Newcomb, Dena M. Carbonari, Jason A. Roy, Jessie Torgersen, Keri N. Althoff, Mari M. Kitahata, K. Rajender Reddy, Joseph K. Lim, Michael J. Silverberg, Angel M. Mayor, Michael A. Horberg, Edward R. Cachay, Gregory D. Kirk, Jing Sun, Mark Hull, M. John Gill, Timothy R. Sterling, Jay R. Kostman, Marion G. Peters, Richard D. Moore, Marina B. Klein, Vincent Lo Re. Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North AmericaHepatology 2021; 74(3): 1190 doi: 10.1002/hep.31839
27
Hiroki Koga, Keita Kai, Shinichi Aishima, Atsushi Kawaguchi, Koutaro Yamaji, Takao Ide, Junji Ueda, Hirokazu Noshiro. Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinomaWorld Journal of Hepatology 2017; 9(35): 1286-1295 doi: 10.4254/wjh.v9.i35.1286
28
Da-Hye Lee, So-Hyun Park, Jiyun Ahn, Seung Pyo Hong, Eunyoung Lee, Young-Jin Jang, Tae-Youl Ha, Yang Hoon Huh, Seung-Yeon Ha, Tae-Il Jeon, Chang Hwa Jung. Mir214-3p and Hnf4a/Hnf4α reciprocally regulate Ulk1 expression and autophagy in nonalcoholic hepatic steatosisAutophagy 2021; 17(9): 2415 doi: 10.1080/15548627.2020.1827779
29
Jeane Rebecca Roy, Coimbatore Sadagopan Janaki, Selvaraj Jayaraman, Vishnu Priya Veeraraghavan, Vijayalakshmi Periyasamy, Thotakura Balaji, Madhavan Vijayamalathi, Ponnusamy Bhuvaneswari, Panneerselvam Swetha. Hypoglycemic Potential of Carica papaya in Liver Is Mediated through IRS-2/PI3K/SREBP-1c/GLUT2 Signaling in High-Fat-Diet-Induced Type-2 Diabetic Male RatsToxics 2023; 11(3): 240 doi: 10.3390/toxics11030240
30
The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical ImplicationsInternational Journal of Molecular Sciences 2019; 20(21): 5266 doi: 10.3390/ijms20215266
31
Ayse Ercan, Mustafa Çelebier, Selin Oncul, Gamze Varan, Engin Kocak, Juan M. Benito, Erem Bilensoy. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular levelInternational Journal of Pharmaceutics 2021; 598: 120379 doi: 10.1016/j.ijpharm.2021.120379
32
Monika Gjorgjieva, Maaike H. Oosterveer, Gilles Mithieux, Fabienne Rajas. Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic EnvironmentJournal of Inborn Errors of Metabolism and Screening 2016; 4: 232640981667942 doi: 10.1177/2326409816679429
33
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeuticsProstaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
34
Lui Ng, Ryan Wai-Yan Sin, David Him Cheung, Wai-Keung Leung, Abraham Tak-Ka Man, Oswens Siu-Hung Lo, Wai-Lun Law, Dominic Chi-Chung Foo. Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp PatientsInternational Journal of Molecular Sciences 2023; 24(10): 9084 doi: 10.3390/ijms24109084
35
Brennan K. Smith, Katarina Marcinko, Eric M. Desjardins, James S. Lally, Rebecca J. Ford, Gregory R. Steinberg. Treatment of nonalcoholic fatty liver disease: role of AMPKAmerican Journal of Physiology-Endocrinology and Metabolism 2016; 311(4): E730 doi: 10.1152/ajpendo.00225.2016
36
Anna Radziejewska, Agata Muzsik, Fermín I. Milagro, J. Alfredo Martínez, Agata Chmurzynska. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and GeneticsLifestyle Genomics 2020; 13(2): 53 doi: 10.1159/000504602
37
Sunday Amos Onikanni, Bashir Lawal, Oluwafemi Shittu Bakare, Basiru Olaitan Ajiboye, Oluwafemi Adeleke Ojo, Abdullah Farasani, Saeed M Kabrah, Gaber El-Saber Batiha, Carlos Adam Conte-Junior. Cancer of the Liver and its Relationship with Diabetes mellitusTechnology in Cancer Research & Treatment 2022; 21: 153303382211197 doi: 10.1177/15330338221119743
38
Jau-Shin Hon, Zhi-Yuan Shi, Chen-Yang Cheng, Zong-You Li. Applying Data Mining to Investigate Cancer Risk in Patients with Pyogenic Liver AbscessHealthcare 2020; 8(2): 141 doi: 10.3390/healthcare8020141
39
Yuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, Yumi Kosaka, Shinsuke Uchikawa, Yuno Nishida, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Wataru Okamoto, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Daiki Miki, Michio Imamura, Shoichi Takahashi, Kazuaki Chayama, Hiroshi Aikata. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year studyBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01884-5
40
Xinmu Zhang, Ruitang Deng. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.81474
41
Kyoko Oura, Asahiro Morishita, Joji Tani, Tsutomu Masaki. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2022; : 1279 doi: 10.2147/JHC.S392051
42
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or ObesityNutrients 2023; 15(23): 4997 doi: 10.3390/nu15234997
43
Laure Monteillet, Monika Gjorgjieva, Marine Silva, Vincent Verzieux, Linda Imikirene, Adeline Duchampt, Hervé Guillou, Gilles Mithieux, Fabienne Rajas. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like contextMolecular Metabolism 2018; 16: 100 doi: 10.1016/j.molmet.2018.07.006
44
Jin‐Mao Li, Jun Zhou, Zhen Xu, Hai‐Jin Huang, Min‐Jiang Chen, Jian‐Song Ji. MicroRNA‐27a‐3p inhibits cell viability and migration through down‐regulating DUSP16 in hepatocellular carcinomaJournal of Cellular Biochemistry 2018; 119(7): 5143 doi: 10.1002/jcb.26526
45
Zhen He, Jian Jun Yang, Rong Zhang, Hua Ting Li, Liang Wu, Feng Jiang, Wei Ping Jia, Cheng Hu. Circulating miR‐29b positively correlates with non‐alcoholic fatty liver disease in a Chinese populationJournal of Digestive Diseases 2019; 20(4): 189 doi: 10.1111/1751-2980.12716
46
Neil E. Caporaso, Rena R. Jones, Rachael Z. Stolzenberg-Solomon, Danielle N. Medgyesi, Lisa L. Kahle, Barry I. Graubard. Insulin Resistance in Healthy U.S. Adults: Findings from the National Health and Nutrition Examination Survey (NHANES)Cancer Epidemiology, Biomarkers & Prevention 2020; 29(1): 157 doi: 10.1158/1055-9965.EPI-19-0206
47
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistanceChemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
48
Hiroyo Ota, Yukio Fujita, Motoo Yamauchi, Shigeo Muro, Hiroshi Kimura, Shin Takasawa. Relationship Between Intermittent Hypoxia and Type 2 Diabetes in Sleep Apnea SyndromeInternational Journal of Molecular Sciences 2019; 20(19): 4756 doi: 10.3390/ijms20194756
49
Juan-Juan Gu, Min Yao, Jie Yang, Yin Cai, Wen-Jie Zheng, Li Wang, Deng-Bing Yao, Deng-Fu Yao. Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesisWorld Journal of Gastroenterology 2017; 23(2): 256-264 doi: 10.3748/wjg.v23.i2.256
50
Xushan Yang, Yudi Deng, Yali Tu, Dongliang Feng, Wenzhen Liao. Nobiletin mitigates NAFLD via lipophagy and inflammationFood & Function 2022; 13(19): 10186 doi: 10.1039/D2FO01682F
51
Charlotte S Benson, Jeremy F Cobbold, Charlotte J Frise. Non-alcoholic fatty liver disease in pregnancyObstetric Medicine 2023; 16(2): 116 doi: 10.1177/1753495X211034709
52
Difei Lu, Zhenfang Yuan, Lihua Yang, Yong Jiang, Min Li, Yuanzheng Wang, Lulu Jing, Rongli Wang, Junqing Zhang, Xiaohui Guo, Carlo Sasso. Body Composition and Metabolic Improvement in Patients Followed Up by a Multidisciplinary Team for Obesity in ChinaJournal of Diabetes Research 2021; 2021: 1 doi: 10.1155/2021/8862217
53
Mehdi Zobeiri, Fatemeh Parvizi, Mohammad Reza Kalhori, Mohammad Bagher Majnooni, Mohammad Hosein Farzaei, Mohammad Abdollahi, Mozaniel Oliveira. Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty LiverEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6641031
54
Sumati Rohilla, Savneet Kaur, Rekha Puria. Advances in Clinical Chemistry 2022; 110: 1 doi: 10.1016/bs.acc.2022.06.001
55
Patricia Rosales-Cruz, Mayra Domínguez-Pérez, Elizabeth Reyes-Zárate, Oscar Bello-Monroy, Cristina Enríquez-Cortina, Roxana Miranda-Labra, Leticia Bucio, Luis Enrique Gómez-Quiroz, Emilio Rojas-Del Castillo, María Concepción Gutiérrez-Ruíz, Verónica Souza-Arroyo. Cadmium exposure exacerbates hyperlipidemia in cholesterol-overloaded hepatocytes via autophagy dysregulationToxicology 2018; : 41 doi: 10.1016/j.tox.2018.02.007
56
Judith Lauvai, Anna‐Karina Becker, Katja Lehnert, Monika Schumacher, Bettina Hieronimus, Walter Vetter, Lutz Graeve. The Furan Fatty Acid 9M5 Acts as a Partial Ligand to Peroxisome Proliferator‐Activated Receptor gamma and Enhances Adipogenesis in 3T3‐L1 PreadipocytesLipids 2019; 54(5): 277 doi: 10.1002/lipd.12152
57
Jacqueline Córdova-Gallardo, Andrew P. Keaveny, Xingshun Qi, Nahum Méndez-Sánchez. Metabolic associated fatty liver disease and acute-on-chronic liver failure: common themes for common problemsEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S): e84 doi: 10.1097/MEG.0000000000002335
58
Yujie Ma, Jinmei Li, Zhengcai Ju, Wendong Huang, Zhengtao Wang, Li Yang, Lili Ding. Danning tablets alleviate high fat diet-induced obesity and fatty liver in mice via modulating SREBP pathwayJournal of Ethnopharmacology 2021; 279: 114320 doi: 10.1016/j.jep.2021.114320
59
Jonathan G. Stine, Brian J. Wentworth, Alex Zimmet, Mary E. Rinella, Rohit Loomba, Stephen H. Caldwell, Curtis K. Argo. Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseasesAlimentary Pharmacology & Therapeutics 2018; 48(7): 696 doi: 10.1111/apt.14937
60
Mikael Kozyra, Inger Johansson, Åsa Nordling, Shahid Ullah, Volker M. Lauschke, Magnus Ingelman-Sundberg. Human hepatic 3D spheroids as a model for steatosis and insulin resistanceScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32722-6
61
Isabela Macedo Lopes Vasques-Monteiro, Flávia Maria Silva-Veiga, Carolline Santos Miranda, Édira Castello Branco de Andrade Gonçalves, Julio Beltrame Daleprane, Vanessa Souza-Mello. A rise in Proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult miceNutrition Research 2021; 91: 26 doi: 10.1016/j.nutres.2021.04.008
62
Pablo Muriel, Pedro López-Sánchez, Erika Ramos-Tovar. Fructose and the LiverInternational Journal of Molecular Sciences 2021; 22(13): 6969 doi: 10.3390/ijms22136969
63
Nissar U. Ashraf, Mohammad Altaf. Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver diseaseMutation Research/Reviews in Mutation Research 2018; 778: 1 doi: 10.1016/j.mrrev.2018.07.002
64
Nicholas J. G. Webster, Deepak Kumar, Panyisha Wu. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinomaScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52237-7
65
José A González-Regueiro, Astrid Ruiz-Margáin, Mariana Cruz-Contreras, Ana M Montaña-Duclaud, Andrea Cavazos-Gómez, Roberta Demichelis-Gómez, Ricardo U Macías-Rodríguez. Clinical characteristics and treatment outcomes in patients with liver cirrhosis and lymphomaWorld Journal of Hepatology 2020; 12(2): 34-45 doi: 10.4254/wjh.v12.i2.34
66
Duminda Suraweera, Peter Konyn, Thomas Vu, Sammy Saab. Clinical Epidemiology of Chronic Liver Diseases2019; : 229 doi: 10.1007/978-3-319-94355-8_15
67
Lena Schulte, Bernhard Scheiner, Torsten Voigtländer, Sandra Koch, Nora Schweitzer, Silke Marhenke, Philipp Ivanyi, Michael P. Manns, Thomas Rodt, Jan B. Hinrichs, Arndt Weinmann, Matthias Pinter, Arndt Vogel, Martha M. Kirstein. Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinomaLiver International 2019; 39(4): 714 doi: 10.1111/liv.14048
68
Marcos C. Carreira, Andrea G. Izquierdo, Maria Amil, Felipe F. Casanueva, Ana B. Crujeiras. Oxidative Stress Induced by Excess of Adiposity Is Related to a Downregulation of Hepatic SIRT6 Expression in Obese IndividualsOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/6256052
69
Bárbara L. Riestra-Candelaria, Loida A. González-Rodríguez, Wilma Rodriguez-Mojica, Luis E. Vázquez-Quiñones, Juan Carlos Jorge. Sonographic Features of the Liver Among Females With Type 2 DiabetesJournal of Diagnostic Medical Sonography 2019; 35(3): 189 doi: 10.1177/8756479319834927
70
Nwe Ni Than, Anwar Ghazanfar, James Hodson, Nadeem Tehami, Chris Coldham, Hynek Mergental, Derek Manas, Tahir Shah, Philip N Newsome, Helen Reeves, Shishir Shetty. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver diseaseQJM 2016; : hcw151 doi: 10.1093/qjmed/hcw151
71
Tarana Arman, Katherine D. Lynch, Michelle L. Montonye, Michael Goedken, John D. Clarke. Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in RatsToxins 2019; 11(7): 398 doi: 10.3390/toxins11070398
72
Wan Mu, Xue-fang Cheng, Ying Liu, Qian-zhou Lv, Gao-lin Liu, Ji-gang Zhang, Xiao-yu Li. Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral TissuesFrontiers in Pharmacology 2019; 9 doi: 10.3389/fphar.2018.01566
73
Omar Ramos-Lopez, Jose I. Riezu-Boj, Fermin I. Milagro, J. Alfredo Martinez. Association of Methylation Signatures at Hepatocellular Carcinoma Pathway Genes with Adiposity and Insulin Resistance PhenotypesNutrition and Cancer 2019; 71(5): 840 doi: 10.1080/01635581.2018.1531136
74
Filomena Morisco, Maria Guarino, Maria R. Valvano, Francesco Auriemma, Fabio Farinati, Edoardo G. Giannini, Francesca Ciccarese, Francesco Tovoli, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Martina Felder, Luisa Benvengù, Antonio Gasbarrini, Gianluca Svegliati Baroni, Francesco G. Foschi, Elisabetta Biasini, Alberto Masotto, Roberto Virdone, Fabio Marra, Nicola Caporaso, Franco Trevisani. Metabolic disorders across hepatocellular carcinoma in ItalyLiver International 2018; 38(11): 2028 doi: 10.1111/liv.13877
75
Jing Sui, Wanshui Yang, Yanan Ma, Tricia Y. Li, Tracey G. Simon, Jeffrey A. Meyerhardt, Geyu Liang, Edward L. Giovannucci, Andrew T. Chan, Xuehong Zhang. A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and MenCancer Prevention Research 2019; 12(6): 367 doi: 10.1158/1940-6207.CAPR-18-0511
76
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbiditiesTerapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
77
Xin Tong, Yu Song, Shengxia Yin, Jian Wang, Rui Huang, Chao Wu, Junping Shi, Jie Li. Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver diseaseChinese Medical Journal 2022; 135(14): 1653 doi: 10.1097/CM9.0000000000002310
78
Ivana Mikolasevic, Sandra Milic, Lidija Orlic, Davor Stimac, Neven Franjic, Giovanni Targher. Factors associated with significant liver steatosis and fibrosis as assessed by transient elastography in patients with one or more components of the metabolic syndromeJournal of Diabetes and its Complications 2016; 30(7): 1347 doi: 10.1016/j.jdiacomp.2016.05.014
79
Mingda Wang, Jun Han, Hao Xing, Han Zhang, Zhenli Li, Lei Liang, Chao Li, Shuyang Dai, Mengchao Wu, Feng Shen, Tian Yang. Dysregulated fatty acid metabolism in hepatocellular carcinomaHepatic Oncology 2016; 3(4): 241 doi: 10.2217/hep-2016-0012
80
I. G. Nikitin, A. S. Tikhomirova, T. A. Zhinzhilo, E. V. Vinnitskaya, Y. G. Sandler, V. A. Kislyakov, I. G. Fedorov. Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 PolymorphismThe Russian Archives of Internal Medicine 2020; 10(2): 148 doi: 10.20514/2226-6704-2020-10-2-148-154
81
Tingting Shi, Hideki Kobara, Kyoko Oura, Tsutomu Masaki. Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 DiabetesJournal of Hepatocellular Carcinoma 2021; : 45 doi: 10.2147/JHC.S274933
82
Deepak MW Balak, Stefano Piaserico, Ismail Kasujee. Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic TherapiesPsoriasis: Targets and Therapy 2021; : 151 doi: 10.2147/PTT.S342911
83
Vahide Betül CANITEZ, İbrahim GÜNEY, Edip ERKUŞ. Metabolik Sendromlu Olmayan Hastalarda Non-Alkolik Yağlı Karaciğer HastalığıBatı Karadeniz Tıp Dergisi 2021; 5(2): 143 doi: 10.29058/mjwbs.811398
84
Xing Liu, Wanshui Yang, Jessica L. Petrick, Linda M. Liao, Weibing Wang, Na He, Peter T. Campbell, Zuo-Feng Zhang, Edward Giovannucci, Katherine A. McGlynn, Xuehong Zhang. Higher intake of whole grains and dietary fiber are associated with lower risk of liver cancer and chronic liver disease mortalityNature Communications 2021; 12(1) doi: 10.1038/s41467-021-26448-9
85
Paula Iruzubieta, Marta González, Joaquín Cabezas, María Teresa Arias-Loste, Javier Crespo. Liver Research and Clinical Management2018;  doi: 10.5772/intechopen.72668
86
Fatema Abu-bakr Abdelmoez, Hala Mostafa Imam, Naglaa Kamal Idriss, Lobna Abdel Wahid, Wael Ahmed Abbas, Mohamed Abozaid Ali Abozaid, Hossam Mahmoud Abdelwahab. The Role of Hepatitis C virus and Possible Risk factors in development of Hepatocellular carcinoma: 400 Patients based studyThe Egyptian Journal of Internal Medicine 2019; 31(1): 64 doi: 10.4103/ejim.ejim_50_18
87
Dafeng Xu, Yu Wang, Kailun Zhou, Jincai Wu, Zhensheng Zhang, Jiachao Zhang, Zhiwei Yu, Luzheng Liu, Xiangmei Liu, Bidan Li, Jinfang Zheng. <p>Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma</p>OncoTargets and Therapy 2020; : 8125 doi: 10.2147/OTT.S263047
88
Juliet Emamaullee, Sara Khan, Carly Weaver, Cameron Goldbeck, George Yanni, Rohit Kohli, Yuri Genyk, Shengmei Zhou, Nick Shillingford, Patrick M. Sullivan, Cheryl Takao, Jon Detterich, Paul F. Kantor, John D. Cleveland, Cynthia Herrington, S. Ram Kumar, Vaughn Starnes, Sarah Badran, Neil D. Patel. Non-invasive biomarkers of Fontan-associated liver diseaseJHEP Reports 2021; 3(6): 100362 doi: 10.1016/j.jhepr.2021.100362
89
Revathy Carnagarin, Kearney Tan, Leon Adams, Vance B. Matthews, Marcio G. Kiuchi, Leslie Marisol Lugo Gavidia, Gavin W. Lambert, Elisabeth A. Lambert, Lakshini Y. Herat, Markus P. Schlaich. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic ActivationInternational Journal of Molecular Sciences 2021; 22(8): 4241 doi: 10.3390/ijms22084241
90
Ali Zarrinpar, Claire M. Faltermeier, Vatche G. Agopian, Bita V. Naini, Michael P. Harlander‐Locke, Fady M. Kaldas, Douglas G. Farmer, Ronald W. Busuttil. Metabolic factors affecting hepatocellular carcinoma in steatohepatitisLiver International 2019; 39(3): 531 doi: 10.1111/liv.14002
91
Ifrath Parveen, Archana Prabhat. Energy Intake and Lifestyle Risk Factors among Non Alcoholic Fatty Liver Disease PatientsThe Indian Journal of Nutrition and Dietetics 2020; : 308 doi: 10.21048/ijnd.2020.57.3.25563
92
Ruojia Ma, Yike Zhan, Yamei Zhang, Liangan Wu, Xing Wang, Ming Guo. Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic miceDrug Development Research 2021;  doi: 10.1002/ddr.21905
93
Yanbiao Ai, Zhenzhen Sun, Chuan Peng, Lingli Liu, Xiaoqiu Xiao, Jibin Li. Homocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed MiceNutrients 2017; 9(4): 346 doi: 10.3390/nu9040346
94
Ahmad Hazim, Dyah Purnamasari, Kemal F. Kalista, C. Rinaldi A. Lesmana, Pringgodigdo Nugroho. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetesDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2): 1431 doi: 10.1016/j.dsx.2019.01.058
95
Siti Aishah Sulaiman, Nor I. A. Muhsin, Rahman Jamal. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver DiseaseFrontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00279
96
Mehrnoosh Zakerkish, Abolghasem Assarzadeh, Seyed Saeed Seyedian, Alireza Jahanshahi. Prevalence of Metabolic Syndrome and Related Factors in Patients with Non-alcoholic Fatty LiverJundishapur Journal of Chronic Disease Care 2021; 11(1) doi: 10.5812/jjcdc.114541
97
Ryutaro Kuraji, Yvonne Kapila, Yukihiro Numabe. Periodontal Disease and Nonalcoholic Fatty Liver Disease: New Microbiome-Targeted Therapy Based on the Oral–Gut–Liver Axis ConceptCurrent Oral Health Reports 2022; 9(3): 89 doi: 10.1007/s40496-022-00312-1
98
Qiaoyou Weng, Minjiang Chen, Weibin Yang, Jie Li, Kai Fan, Min Xu, Wei Weng, Xiuling Lv, Shiji Fang, Liyun Zheng, Jingjing Song, Zhongwei Zhao, Xiaoxi Fan, Jiansong Ji. Integrated analyses identify miR‐34c‐3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinomaThe FASEB Journal 2020; 34(4): 5420 doi: 10.1096/fj.201902895R
99
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
100
I. Mikolasevic, S. Milic, L. Orlic, G. Poropat, I. Jakopcic, N. Franjic, A. Klanac, N. Kristo, D. Stimac. Metabolic syndrome and acute pancreatitisEuropean Journal of Internal Medicine 2016; 32: 79 doi: 10.1016/j.ejim.2016.04.004
101
Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac, Sandra Milic. Transient elastography (FibroScan<sup>&reg;</sup>) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?World Journal of Gastroenterology 2016; 22(32): 7236-7251 doi: 10.3748/wjg.v22.i32.7236
102
Laura Elvira-Torales, Gala Martín-Pozuelo, Rocío González-Barrio, Inmaculada Navarro-González, Francisco-José Pallarés, Marina Santaella, Javier García-Alonso, Ángel Sevilla, María Periago-Castón. Ameliorative Effect of Spinach on Non-Alcoholic Fatty Liver Disease Induced in Rats by a High-Fat DietInternational Journal of Molecular Sciences 2019; 20(7): 1662 doi: 10.3390/ijms20071662
103
Min Wang, Minxian Wang, Ru Zhang, Chao Shen, Liuxin Zhang, Yajie Ding, Zongzhe Tang, Hongliang Wang, Wei Zhang, Yue Chen, Jie Wang. Influences of Vitamin D Levels and Vitamin D-Binding Protein Polymorphisms on Nonalcoholic Fatty Liver Disease Risk in a Chinese PopulationAnnals of Nutrition and Metabolism 2022; 78(2): 61 doi: 10.1159/000522193
104
Dora Lucía Vallejo-Ardila, Marco A. De Bastiani, Diego A. Salazar. Hepatobiliary Cancers: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2022; 3: 193 doi: 10.1007/16833_2022_40
105
Ahmet UYANIKOĞLU. Siroz etiyolojisinde steatohepatitin yeri nedir?Akademik Gastroenteroloji Dergisi 2019; 19(1): 17 doi: 10.17941/agd.723285
106
Hsien Min Low, Jin Young Choi, Cher Heng Tan. Pathological variants of hepatocellular carcinoma on MRI: emphasis on histopathologic correlationAbdominal Radiology 2019; 44(2): 493 doi: 10.1007/s00261-018-1749-z
107
Ryutaro Kuraji, Satoshi Sekino, Yvonne Kapila, Yukihiro Numabe. Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axisPeriodontology 2000 2021; 87(1): 204 doi: 10.1111/prd.12387
108
Thomas J. Vogl, Tatjana Gruber-Rouh. HCC: Transarterial Therapies—What the Interventional Radiologist Can OfferDigestive Diseases and Sciences 2019; 64(4): 959 doi: 10.1007/s10620-019-05542-5
109
Chenyi Wang, Qianglong Niu, Haihong Lv, Qian Li, Yuping Ma, Jiaojiao Tan, Chunhua Liu. <p>Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case–Control Study</p>Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 4369 doi: 10.2147/DMSO.S280231
110
Yan Guo, Yanhua Xiong, Quanghu Sheng, Shilin Zhao, Julia Wattacheril, Charles Robb Flynn. A micro-RNA expression signature for human NAFLD progressionJournal of Gastroenterology 2016; 51(10): 1022 doi: 10.1007/s00535-016-1178-0
111
John D. Clarke, Anika Dzierlenga, Tarana Arman, Erica Toth, Hui Li, Katherine D. Lynch, Dan-Dan Tian, Michael Goedken, Mary F. Paine, Nathan Cherrington. Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicityToxicon 2019; 162: 1 doi: 10.1016/j.toxicon.2019.03.002
112
Sarawoot Bunbupha, Poungrat Pakdeechote, Putcharawipa Maneesai, Patoomporn Prasarttong. Nobiletin alleviates high-fat diet-induced nonalcoholic fatty liver disease by modulating AdipoR1 and gp91phox expression in ratsThe Journal of Nutritional Biochemistry 2021; 87: 108526 doi: 10.1016/j.jnutbio.2020.108526